Metin Kurtoglu

Insider Reports History

Entity
Individual
Location
C/O Cartesian Therapeutics, Inc., 704 Quince Orchard Rd, Gaithersburg, MD
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Metin Kurtoglu
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Metin Kurtoglu:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cartesian Therapeutics, Inc. Chief Technology Officer Common Stock 51K $851K $16.67 Nov 21, 2024 Direct
Cartesian Therapeutics, Inc. Chief Technology Officer Stock Option (Right to Buy) 92.8K $73.3K $0.79 Nov 21, 2024 Direct

Insider Reports Filed by Metin Kurtoglu

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RNAC Cartesian Therapeutics, Inc. Nov 19, 2024 10 -$594K 4 Nov 21, 2024 Chief Technology Officer
RNAC Cartesian Therapeutics, Inc. Nov 14, 2024 11 -$1.32M 4 Nov 18, 2024 Chief Technology Officer
RNAC Cartesian Therapeutics, Inc. Apr 8, 2024 6 $0 4 Apr 10, 2024 Chief Technology Officer
RNAC Cartesian Therapeutics, Inc. Jan 2, 2024 2 $0 4 Jan 4, 2024 Chief Operating Officer
SELB Cartesian Therapeutics, Inc. Nov 13, 2023 3 $0 4 Nov 15, 2023 Chief Operations Officer
SELB Cartesian Therapeutics, Inc. Nov 13, 2023 0 $0 3 Nov 15, 2023 Chief Operations Officer